Transmucosal Drug Delivery device is intended for the localized delivery of medications through a mucous membrane.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Transmucosal Drug Delivery under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Transmucosal Drug Delivery and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Transmucosal Drug Delivery under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AFYX Therapeutics A/S
- Albert Einstein College of Medicine
- Allergan Ltd
- Altamira Medica AG
- Amphastar Pharmaceuticals Inc
- Anelleo Inc
- Aquestive Therapeutics Inc
- Arovella Therapeutics Ltd
- ARS Pharmaceuticals Inc
- Atossa Therapeutics Inc
- Auris Medical AG
- Auritec Pharmaceuticals Inc
- BeFree!
- Bespak Europe Ltd
- Biorings LLC
- BioXcel Therapeutics Inc
- Birmingham Biotech Ltd
- Bryn Pharma LLC
- Callitas Therapeutics Inc (Inactive)
- Chulalongkorn University
- Combinent BioMedical Systems Inc
- Conrad
- Covidrops LLP
- CS Medica A/S
- Dare Bioscience Inc
- Eledon Pharmaceuticals Inc
- Emergent BioSolutions Inc
- EmphyCorp Inc
- Ena Respiratory Pty Ltd
- Eureka Therapeutics Inc
- Eveon SAS
- Evestra Inc
- Evofem Biosciences Inc
- Ferring Pharmaceuticals AS
- Firebrick Pharma Pty Ltd
- GeneOne Life Science Inc
- Ghent University
- Glenmark Pharmaceuticals Ltd
- Grasses of Eden Ltd
- Grunenthal Ltd
- Halberd Corp
- Hebrew University of Jerusalem
- Hikma Pharmaceuticals Plc
- Hovione FarmaCiencia SA
- Imbed Biosciences Inc
- Indivior Plc
- Institute for Research and Innovation in Health
- Insys Therapeutics Inc (Inactive)
- IntelGenx Corp
- International Partnership For Microbicides
- ITC Life Sciences and Technology Centre
- ITF Pharma Inc
- Janssen Sciences Ireland UC
- Kane Biotech Inc
- Karessa Pharma AB
- Karp Lab
- Kiora Pharmaceuticals Inc
- Kurve Therapeutics Inc
- Kytogenics Pharmaceuticals Inc
- Laboratoire HRA Pharma SAS
- Lachesis Biosciences Ltd
- Leyden Laboratories BV
- Lobe Sciences Ltd
- Lyra Therapeutics Inc
- Magee-Womens Research Institute
- MassBiologics
- McNeil AB
- Medlab Clinical Ltd
- Merck & Co Inc
- Merck Serono SA
- Milestone Pharmaceuticals USA Inc
- Mucommune LLC
- Mycrodose Therapeutics Inc
- Mystic Pharmaceuticals Inc
- Nanosys Inc
- Nasus Medical Inc
- Nasus Pharma Ltd
- Nemera La Verpilliere
- NorInvent AB
- Novlead Biotechnology Co Ltd
- Olfax LLC
- Opiant Pharmaceuticals Inc
- OptiNose AS
- OptiNose Inc
- Organon Pharma (UK) Ltd
- Orion Biotechnology Canada Ltd
- Orphanse Healthcare SAS
- Oyster Point Pharma Inc
- P&B Group
- Palette Life Sciences AB
- Parnell Pharmaceuticals Inc
- pHOXBIO Ltd
- Pocket Naloxone Corp
- Polyrizon Ltd
- RDD Pharma Ltd (Inactive)
- Renown Pharmaceuticals Pvt Ltd
- Rhinomed Ltd
- Sanotize Research and Development Corp
- Scientus Pharma Inc (Inactive)
- Seelos Therapeutics, Inc.
- Shin Nippon Biomedical Laboratories Ltd
- SipNose
- South Valley University
- Starpharma Holdings Ltd
- Talphera Inc
- The Population Council Inc
- The University of Texas at Austin Division of Housing and Food Service
- Therakind Ltd
- Transire Bio
- Union Therapeutics AS
- University of Kentucky
- University of Louisville
- University of Melbourne
- University of North Carolina at Chapel Hill
- University of Pittsburgh
- University of South Florida
- University of the Witwatersrand
- University of Waterloo
- Virpax Pharmaceuticals Inc
- VistaGen Therapeutics Inc
- Washington University in St Louis
- Wellfully Ltd
- Xlear Inc
- Zydus Healthcare Ltd